Descriptive Study in Patients Treated With Vimovo™, Including Registration of the Physicians' Prescribing Patterns
NCT ID: NCT01511926
Last Updated: 2015-03-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2000 participants
OBSERVATIONAL
2012-01-31
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis
NCT00141102
A Study to Evaluate the Analgesic Efficacy and Safety of VM902A in Subjects With Osteoarthritis (OA) of the Knee
NCT02847702
Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis
NCT00665431
Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis
NCT00664560
Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis (OA) of the Knee
NCT01688934
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Adult patients treated with Vimovo™ for diagnosed osteoarthritis (OA), rheumatoid arthritis (RA) or ankylosing spondylitis
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients started on Vimovo during the first 3 months after country-specific launch date
* Patients started on Vimovo after the study site is initiated (in order to avoid influence on prescribing decision and recruitment)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Javier Nuevo, MSC
Role: STUDY_DIRECTOR
Medical Department, AstraZeneca Spain
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Aalst, , Belgium
Research Site
Dilbeek, , Belgium
Research Site
Erembodegem, , Belgium
Research Site
Genk, , Belgium
Research Site
Halen, , Belgium
Research Site
Heers, , Belgium
Research Site
Huy, , Belgium
Research Site
Langemark, , Belgium
Research Site
Lasne, , Belgium
Research Site
Lembeke, , Belgium
Research Site
Melsele, , Belgium
Research Site
Morkhoven, , Belgium
Research Site
Olen, , Belgium
Research Site
Sart-lez-Spa, , Belgium
Research Site
Sint-Lievens-Houtem, , Belgium
Research Site
Tessenderlo, , Belgium
Research Site
Wambeek, , Belgium
Research Site
Wingene, , Belgium
Research Site
Zonhoven, , Belgium
Research Site
Helsinki, , Finland
Research Site
Hyvinkää, , Finland
Research Site
Vantaa, , Finland
Research Site
Bad Brückenau, , Germany
Research Site
Blankenhain, , Germany
Research Site
Deggingen, , Germany
Research Site
Freiberg, , Germany
Research Site
Gersthofen, , Germany
Research Site
Hagen, , Germany
Research Site
Lienen, , Germany
Research Site
Löhne, , Germany
Research Site
München, , Germany
Research Site
Stockach, , Germany
Research Site
's-Hertogenbosch, , Netherlands
Research Site
Andijk, , Netherlands
Research Site
Beek en Donk, , Netherlands
Research Site
Dordrecht, , Netherlands
Research Site
Eersel, , Netherlands
Research Site
Heesch, , Netherlands
Research Site
Hoogwoud, , Netherlands
Research Site
Midwoud, , Netherlands
Research Site
Nijverdal, , Netherlands
Research Site
Ravenstein, , Netherlands
Research Site
Sint Geertruid, , Netherlands
Research Site
Spijkernisse, , Netherlands
Research Site
Vlodrop, , Netherlands
Research Site
Bøverbru, , Norway
Research Site
Eidsvoll, , Norway
Research Site
Kirkenær, , Norway
Research Site
Kråkerøy, , Norway
Research Site
Oslo, , Norway
Research Site
Røa, , Norway
Research Site
Skarnes, , Norway
Research Site
Sola, , Norway
Research Site
Stavanger, , Norway
Research Site
Strømmen, , Norway
Research Site
Svelvik, , Norway
Research Site
Tananger, , Norway
Research Site
Tønsberg, , Norway
Research Site
Østerås, , Norway
Research Site
Las Bayas, Elche, Elche, Spain
Research Site
Badalona, , Spain
Research Site
Barcelona, , Spain
Research Site
Benaguasil, Valencia, , Spain
Research Site
Elda, Alicante, , Spain
Research Site
Esplugues de Llobregat, , Spain
Research Site
Merida, Badajoz, , Spain
Research Site
Rianxo, A Coruna, , Spain
Research Site
San Fernando, Cadiz, , Spain
Research Site
Santiago de Compostela, , Spain
Research Site
Seville, , Spain
Research Site
Teruel, , Spain
Research Site
Torrelavega, Cantabria, , Spain
Research Site
Valencia, , Spain
Research Site
Vilanova i la Geltrú, , Spain
Research Site
Xativa, Valencia, , Spain
Research Site
Zaragoza, , Spain
Research Site
Basel, , Switzerland
Research Site
Bellinzona, , Switzerland
Research Site
Chur, , Switzerland
Research Site
Ebmatingen, , Switzerland
Research Site
Neftenbach / Dorf Neftenbach, , Switzerland
Research Site
Paradiso, , Switzerland
Research Site
Sankt Gallen, , Switzerland
Research Site
Schiers, , Switzerland
Research Site
Seuzach Dorf, , Switzerland
Research Site
St. Erhard, , Switzerland
Research Site
Zurich, , Switzerland
Research Site
Addingham, , United Kingdom
Research Site
Basildon, , United Kingdom
Research Site
Belfast, , United Kingdom
Research Site
Birmingham, , United Kingdom
Research Site
Chippenham, , United Kingdom
Research Site
Heywood, , United Kingdom
Research Site
Randalstown, , United Kingdom
Research Site
Sheffield, , United Kingdom
Research Site
Warminster, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D1120C00044
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.